by BGIS | Oct 16, 2020 | Top Stories
(Stock Photo) The Barbados Drug Service (BDS) is advising the public that the metformin products, used to treat diabetes, currently supplied through the Barbados Drug Service in the public pharmacies and the private participating pharmacies, are not included in those...
by Joy-Ann Gill | Apr 23, 2020 | Top Stories
(Stock Photo) The Department of Commerce and Consumer Affairs (DCCA) is again advising consumers not to use Ranitidine medication following its previous recall of October 2019. This comes against the backdrop that the Food and Drug Administration (FDA) in the United...
by BGIS | Jan 7, 2019 | Top Stories
Statement from the Ministry of Health and Wellness on Valsartan 160mg and 320mg, and Indapamide 1.5mg Recall The Ministry of Health and Wellness wishes to inform Barbadians that recent analytical results from the Medicines Quality Control and Surveillance Department...
by Joy Springer | Jan 5, 2019 | Top Stories
The Ministry of Health and Wellness is assuring the public that none of the drugs identified in the December 31 recall of the hypertensive drug, Valsartan, by the United States Food and Drug Administration (FDA) is approved by the Barbados Drug Service for sale in...
by Joy Springer | Dec 17, 2018 | Top Stories
The Ministry of Health and Wellness has assured the public that Barbados has not been affected by the current recall of the hypertensive drug, Valsartan. The drug has been recalled due to an impurity found in a batch of products. Acting Chief Medical Officer, Dr....
